APA (7th ed.) Citation

MA, S., MA, R., NN, E. M., YAM, E., NS, E. S., & SM, M. (2025). Unlocking dexmedetomidine's therapeutic potential in multiple sclerosis: Dual modulation of PI3K/Akt/BDNF and TLR4/NF-κB pathways in EAE rats. European journal of pharmacology, 1008, 178365. https://doi.org/10.1016/j.ejphar.2025.178365

Chicago Style (17th ed.) Citation

MA, Salem, Rabie MA, El Maraghy NN, El-Said YAM, El Sayed NS, and Mansour SM. "Unlocking Dexmedetomidine's Therapeutic Potential in Multiple Sclerosis: Dual Modulation of PI3K/Akt/BDNF and TLR4/NF-κB Pathways in EAE Rats." European Journal of Pharmacology 1008 (2025): 178365. https://doi.org/10.1016/j.ejphar.2025.178365.

MLA (9th ed.) Citation

MA, Salem, et al. "Unlocking Dexmedetomidine's Therapeutic Potential in Multiple Sclerosis: Dual Modulation of PI3K/Akt/BDNF and TLR4/NF-κB Pathways in EAE Rats." European Journal of Pharmacology, vol. 1008, 2025, p. 178365, https://doi.org/10.1016/j.ejphar.2025.178365.